Published • loading... • Updated
Recognizing the Signs of Pediatric Growth Hormone Deficiency: How Early Recognition and Advocacy Helped One Family Find Answers
The diagnosis followed bloodwork, a bone age X-ray, a growth hormone test and an MRI, and insurance later required a daily drug trial.
- Diane Benke grew concerned about her son Alex's growth around age 7, but their pediatrician initially dismissed her worries. Benke persisted and secured a pediatric endocrinologist appointment that confirmed pediatric growth hormone deficiency .
- Alex underwent comprehensive evaluations including bloodwork, a bone age X-ray, a growth hormone stimulation test, and a brain MRI to rule out pituitary abnormalities. These tests confirmed PGHD, a rare condition affecting an estimated 1 in 4,000-10,000 children.
- Insurance required Alex to trial daily somatropin injections for three months before approving a weekly long-acting growth hormone option. Benke explained the switch provided peace of mind and helped the family focus on being together again.
- The weekly treatment significantly improved adherence, with Benke noting minimal disruptions to daily routine and that Alex has not missed a single dose since switching. The shift restored normalcy to the family's daily life.
- Benke urges parents to "trust your instincts" and seek specialists if growth concerns persist, noting that early detection is critical. Treatment becomes less effective once a child's bones stop growing, making timely intervention essential.
Insights by Ground AI
122 Articles
122 Articles
Coverage Details
Total News Sources122
Leaning Left13Leaning Right7Center85Last UpdatedBias Distribution81% Center
Bias Distribution
- 81% of the sources are Center
81% Center
12%
C 81%
Factuality
To view factuality data please Upgrade to Premium
